{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:35:35Z","timestamp":1791207335409,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.leukres.2022.106825","type":"journal-article","created":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T10:57:33Z","timestamp":1647082653000},"page":"106825","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Population-based targeted RNA sequencing reveals novel disease-related gene fusions in pediatric and adult T-ALL"],"prefix":"10.1016","volume":"116","author":[{"given":"Rimvydas","family":"Norvilas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raminta","family":"Batiuskaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaidas","family":"Dirse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruta","family":"Semaskeviciene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egle","family":"Gineikiene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mindaugas","family":"Stoskus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goda","family":"Vaitkeviciene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Rascon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laimonas","family":"Griskevicius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.leukres.2022.106825_bib1","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1172\/JCI61269","article-title":"The molecular basis of T cell acute lymphoblastic leukemia","volume":"122","author":"Van Vlierberghe","year":"2012","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.leukres.2022.106825_bib2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1535-6108(02)00018-1","article-title":"Gene expression signatures define novel oncogenic pathways in T-cell acute lymphoblastic leukmia","volume":"1","author":"Ferrando","year":"2002","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.leukres.2022.106825_bib3","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3324\/haematol.2008.004150","article-title":"T-cell acute lymphoblastic leukemia","volume":"94","author":"Chiaretti","year":"2009","journal-title":"Haematologica"},{"issue":"9","key":"10.1016\/j.leukres.2022.106825_bib4","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1182\/blood-2016-10-706465","article-title":"The genetics and molecular biology of T-ALL","volume":"129","author":"Girardi","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2022.106825_bib5","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1038\/sj.leu.2404302","article-title":"T-cell acute lymphoblastic leukemia: from thymocyte to lymphoblast","volume":"20","author":"Graux","year":"2006","journal-title":"Leukemia"},{"issue":"40","key":"10.1016\/j.leukres.2022.106825_bib6","doi-asserted-by":"crossref","first-page":"65485","DOI":"10.18632\/oncotarget.11796","article-title":"Genomic characterization of pediatric T-cell acute 60 lymphoblastic leukemia reveals novel recurrent driver mutations","volume":"7","author":"Spinella","year":"2016","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.leukres.2022.106825_bib7","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/ng.3909","article-title":"The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia","volume":"49","author":"Liu","year":"2017","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.leukres.2022.106825_bib8","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nri2304","article-title":"Molecular pathogenesis of T-cell leukaemia and lymphoma","volume":"8","author":"Aifantis","year":"2008","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.leukres.2022.106825_bib9","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1073\/pnas.1717125115","article-title":"Identification of fusion genes and characterization of transcriptome features in T-cell acute lymphoblastic leukemia","volume":"115","author":"Chen","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.leukres.2022.106825_bib10","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/sj.leu.2404187","article-title":"HOXA cluster deregulation in T-ALL associated with both a TCRD-HOXA and a CALM-AF10 chromosomal translocation","volume":"20","author":"Bergeron","year":"2006","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.leukres.2022.106825_bib11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ccr.2012.06.007","article-title":"Core transcriptional regulatory circuit controlled by the TAL1 complex in human T cell acute lymphoblastic leukemia","volume":"22","author":"Sanda","year":"2012","journal-title":"Cancer Cell"},{"issue":"25","key":"10.1016\/j.leukres.2022.106825_bib12","doi-asserted-by":"crossref","first-page":"e413","DOI":"10.1200\/JCO.2012.47.6770","article-title":"Tyrosine kinase inhibitor therapy induces remission in a patient with refractory EBF1-PDGFRB-positive acute lymphoblastic leukemia","volume":"31","author":"Weston","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.leukres.2022.106825_bib13","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.3324\/haematol.2015.136499","article-title":"NUP214-ABL1 fusion defines a rare subtype of B-cell precursor acute lymphoblastic leukemia that could benefit from tyrosine kinase inhibitors","volume":"101","author":"Duployez","year":"2016","journal-title":"Haematologica"},{"issue":"20","key":"10.1016\/j.leukres.2022.106825_bib14","first-page":"1657","article-title":"Oncogenic role and therapeutic targeting of ABL-class and JAK-STAT activating kinase alterations in Ph-like ALL","volume":"1","author":"Roberts","year":"2017","journal-title":"Blood Adv."},{"issue":"12","key":"10.1016\/j.leukres.2022.106825_bib15","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1038\/sj.leu.2401592","article-title":"Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia","volume":"13","author":"van Dongen","year":"1999","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.leukres.2022.106825_bib16","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3324\/haematol.2008.005272","article-title":"Prognostic implications of NOTCH1 and FBXW7 mutations in adult acute T-lymphoblastic leukemia","volume":"94","author":"Baldus","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2022.106825_bib17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/leu.2012.176","article-title":"Impact of NOTCH1\/FBXW7 mutations on outcome in pediatric T-cell acute lymphoblastic leukemia patiens treated on MRC UKALL 2003 trials","volume":"27","author":"Jenkinson","year":"2013","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.leukres.2022.106825_bib18","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/gcc.22039","article-title":"The molecular profile of adult T-cell acute lymphoblastic leukemia: mutations in RUNX1 and DNMT3A are associated with poor prognosis in T-ALL","volume":"52","author":"Grossmann","year":"2013","journal-title":"Gene Chromosome Cancer"},{"key":"10.1016\/j.leukres.2022.106825_bib19","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1038\/leu.2014.89","article-title":"Novel activating STAT5B mutations as putative drivers of T-cell acute lymphoblastic leukemia","volume":"28","author":"Kontro","year":"2014","journal-title":"Leukemia"},{"issue":"40","key":"10.1016\/j.leukres.2022.106825_bib20","doi-asserted-by":"crossref","first-page":"11306","DOI":"10.1073\/pnas.1608420113","article-title":"Mutational landscape, clonal evolution patterns, and role of RAS mutations in relapsed acute lymphoblastic leukemia","volume":"113","author":"Oshima","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.leukres.2022.106825_bib21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1756-8722-2-3","article-title":"SET-NUP214 fusion in acute myeloid leukemia- and T-Cell acute lymphoblastic leukemia-derived cell lines","volume":"2","author":"Quentmeier","year":"2009","journal-title":"J. Hematol. Oncol."},{"issue":"12","key":"10.1016\/j.leukres.2022.106825_bib22","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1182\/blood-2013-08-521518","article-title":"SET-NUP12 is a recurrent \u03b3\u03b4 lineage-specific fusion transcript associated with corticosteroid\/chemoterapy resistance in adult T-ALL","volume":"132","author":"Abdelali","year":"2014","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.leukres.2022.106825_bib23","doi-asserted-by":"crossref","first-page":"959","DOI":"10.3892\/ol.2014.2263","article-title":"NUP214 fusion genes in acute leukemia","volume":"8","author":"Zhou","year":"2014","journal-title":"Oncol. Lett."},{"issue":"8","key":"10.1016\/j.leukres.2022.106825_bib24","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1080\/10428190903040014","article-title":"SIL-TAL1 fusion gene negative impact in T-cell acute lymphoblastic leukemia outcome","volume":"50","author":"Mansur","year":"2009","journal-title":"Leuk. Lymphoma"},{"issue":"1","key":"10.1016\/j.leukres.2022.106825_bib25","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.3324\/haematol.2014.112151","article-title":"Clinical features and outcome of SIL\/TAL1-positive T-cell acute lymphoblastic leukemia in children and adolescents: a 10-year experience of the AIEOP group","volume":"100","author":"D'Angi\u00f2","year":"2015","journal-title":"Haematologica"},{"issue":"25","key":"10.1016\/j.leukres.2022.106825_bib26","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1182\/blood-2013-02-487256","article-title":"New MLLT10 gene recombinations in pediatric T-acute lymphoblastic leukemia","volume":"121","author":"Brandimarte","year":"2013","journal-title":"Blood"},{"issue":"7380","key":"10.1016\/j.leukres.2022.106825_bib27","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nature10725","article-title":"The genetic basis of early T-cell precursor acute lymphoblastic laukaemia","volume":"481","author":"Zhang","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2022.106825_bib28","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1182\/blood-2019-130768","article-title":"NUP98-KDM5A fusion induces hematopoietic cell proliferation and alters meylo-erythropoietic differentiation","volume":"134","author":"Miller","year":"2019","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2022.106825_bib29","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.1038\/s41598-019-41675-3","article-title":"Detection of novel fusion-transcripts by RNA-Seq in T-cell lymphoblastic lymphoma","volume":"9","author":"L\u00f3pez-Nieva","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.leukres.2022.106825_bib30","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3324\/haematol.2009.011536","article-title":"TFG, a target of chromosome translocations in lymphoma and soft tissue tumors, fuses to GPR128 in healthy individuals","volume":"95","author":"Chase","year":"2010","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.leukres.2022.106825_bib31","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/gcc.21932","article-title":"Identification of TFG (TRK-fused gene) as a putative metastatic melanoma tumor suppressor gene","volume":"51","author":"Dutton-Regester","year":"2012","journal-title":"Genes Chromosomes Cancer"},{"issue":"2","key":"10.1016\/j.leukres.2022.106825_bib32","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ijc.30081","article-title":"Characterization of functionally active gene fusions in human papillomavirus related oropharyngeal squamous cell carcinoma","volume":"139","author":"Guo","year":"2016","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.leukres.2022.106825_bib33","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1182\/blood.V83.2.415.415","article-title":"Flow cytometric assessment of human MIC2 expression in bone marrow, thymus, and peripheral blood","volume":"83","author":"Dworzak","year":"1994","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.leukres.2022.106825_bib34","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.4049\/jimmunol.127.6.2269","article-title":"A monoclonal antibody specific for immature human hemopoietic cells and T lineage cells","volume":"127","author":"Bodger","year":"1981","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.leukres.2022.106825_bib35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1242\/jcs.175521","article-title":"Multifunctional Abl kinases in healt and disease","volume":"129","author":"Khatri","year":"2016","journal-title":"J. Cell Sci."},{"issue":"1","key":"10.1016\/j.leukres.2022.106825_bib36","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s12079-017-0445-z","article-title":"CD99 at the crossroads of physiology and pathology","volume":"12","author":"Pasello","year":"2018","journal-title":"J. Cell Commun. Signal"},{"issue":"6","key":"10.1016\/j.leukres.2022.106825_bib37","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0092-8674(03)00194-6","article-title":"Structural basis for the autoinhibition of c-Abl tyrosine kinase","volume":"112","author":"Nagar","year":"2003","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.leukres.2022.106825_bib38","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1046\/j.1365-2141.2002.03850.x","article-title":"Identification of an ETV6-ABL2 fusion transcript in combination with an ETV6 point mutation in a T-cell acute lymphoblastic leukemia cell line","volume":"119","author":"Griesinger","year":"2002","journal-title":"Br. J. Haematol."},{"issue":"3","key":"10.1016\/j.leukres.2022.106825_bib39","doi-asserted-by":"crossref","first-page":"4618","DOI":"10.18632\/oncotarget.13492","article-title":"Tyrosine kinase fusion genes in pediatric BCR-ABL1-like acute lymphoblastic leukemia","volume":"8","author":"Boer","year":"2017","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.leukres.2022.106825_bib40","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1084\/jem.185.8.1467","article-title":"Impairment of T cell development in deltaEF1 mutant mice","volume":"185","author":"Higashi","year":"1997","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.leukres.2022.106825_bib41","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1182\/blood-2008-01-131185","article-title":"Down-regulation of TCF8 is involved in the leukemogenesis of adult T-cell leukemia\/lymphoma","volume":"112","author":"Hidaka","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2022.106825_bib42","first-page":"8","article-title":"The formin mDia1 regulates acute lymphoblastic leukemia engraftment, migration and progression in vivo","author":"Thompson","year":"2018","journal-title":"Front. Oncol."},{"issue":"12","key":"10.1016\/j.leukres.2022.106825_bib43","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.3324\/haematol.2012.064659","article-title":"Alternative TEL-JAK2 fusions associated with T-cell acute lymphoblastic leukemia and atypical chronic myelogenous leukemia dissected in zebrafish","volume":"97","author":"Onnebo","year":"2012","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.leukres.2022.106825_bib44","article-title":"Transforming and tumorigenic activity of JAK2 by fusion to BCR: molecular mechanisms of action of a novel BCR-JAK2 tyrosine-kinase","volume":"7","author":"Custa-Dom\u00ednguez","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.leukres.2022.106825_bib45","first-page":"1278","article-title":"NPM1c impedes CTCF functions through cytoplasmic mislocalization in acute myeloid leukemia","volume":"34","author":"Wang","year":"2020"},{"issue":"3","key":"10.1016\/j.leukres.2022.106825_bib46","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1182\/blood.2019002326","article-title":"AML displays increased CTCF occupancy associated with aberrant gene expression and transcription factor binding","volume":"136","author":"Mujahed","year":"2020","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.leukres.2022.106825_bib47","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1080\/15384101.2015.1084445","article-title":"Targeting CDK6 in cancer: state of the art and new insights","volume":"14","author":"Tadesse","year":"2015","journal-title":"Cell Cycle"},{"issue":"1","key":"10.1016\/j.leukres.2022.106825_bib48","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1182\/blood-2014-06-584417","article-title":"CDK6 as key regulator of hematopoietic and leukemic stem cell activation","volume":"125","author":"Scheicher","year":"2015","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.leukres.2022.106825_bib49","doi-asserted-by":"crossref","first-page":"655","DOI":"10.4161\/cc.10.4.14814","article-title":"Nek1 kinase functions in DNA damage response and checkpoint control through a pathway independent of ATM and ATR","volume":"10","author":"Chen","year":"2011","journal-title":"Cell Cycle"},{"issue":"16","key":"10.1016\/j.leukres.2022.106825_bib50","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.4161\/cc.25624","article-title":"Nek1 interacts with Ku80 to assist chromatin loading of replication factors and S-phase progression","volume":"12","author":"Patil","year":"2013","journal-title":"Cell Cycle"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212622000510?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212622000510?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:01:49Z","timestamp":1758934909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212622000510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":50,"alternative-id":["S0145212622000510"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2022.106825","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Population-based targeted RNA sequencing reveals novel disease-related gene fusions in pediatric and adult T-ALL","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2022.106825","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106825"}}